ELAN

Elanco Animal Health Incorporated [ELAN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ELAN Stock Summary

Top 10 Correlated ETFs

ELAN


In the News

12:14 29 Mar 2024 ELAN

Elanco Animal Health (ELAN) CEO on Pet Disease Prevention & Health Products

Elanco Animal Health (ELAN) offers pet disease prevention and nutritional health products. CEO Jeffrey Simmons joins Oliver Renick to give an overview of the company.

10:31 29 Mar 2024 ELAN

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings

The headline numbers for Elanco Animal Health Incorporated (ELAN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

10:20 29 Mar 2024 ELAN

Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Elanco Animal Health Incorporated (ELAN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

11:05 29 Mar 2024 ELAN

Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

08:24 29 Mar 2024 ELAN

Elanco Animal Health sells aqua business to Merck for $1.3 billion

Elanco Animal Health Inc has announced the sale of its aqua business to Merck Animal Health for US$1.3 billion in a bid to refocus on other markets. This will enable Elanco to accelerate debt paydown by US$1.05 billion to US$1.1 billion, the company said on Monday, with the proceeds representing over seven times the estimated 2023 revenue of the hot and cold water species product firm.

06:43 29 Mar 2024 ELAN

Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cash

Elanco Animal Health Inc. ELAN, -0.41% said Monday it has agreed to sell its aqua business to Merck Animal Health MRK, +0.02% for $1.3 billion in cash. Greenfield, Ind.

09:01 29 Mar 2024 ELAN

Strength Seen in Elanco Animal Health Incorporated (ELAN): Can Its 6.2% Jump Turn into More Strength?

Elanco Animal Health Incorporated (ELAN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

11:19 29 Mar 2024 ELAN

Stifel: ‘party is just getting started' in this stock up 80%

Elanco Animal Health Inc (NYSE: ELAN) has already gained a whopping 80% over the past two months but a Stifel analyst is convinced that the “party is just getting started”.

10:31 29 Mar 2024 ELAN

Elanco Animal Health Incorporated (ELAN) Hit a 52 Week High, Can the Run Continue?

Elanco Animal Health Incorporated (ELAN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

06:37 29 Mar 2024 ELAN

Ancora picks up a stake in Elanco. How the investor may push to help improve margins

A refreshment of the board may be on the horizon at the animal health company.

ELAN Financial details

Company Rating
Neutral
Market Cap
7.8B
Income
-1.23B
Revenue
4.42B
Book val./share
12.63
Cash/share
0.71
Dividend
-
Dividend %
-
Employees
9.3K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-6.64
Forward P/E
65.18
PEG
-0.04
P/S
1.74
P/B
1.24
P/C
22.95
P/FCF
-116.83
Quick Ratio
1.19
Current Ratio
2.82
Debt / Equity
0.93
LT Debt / Equity
0.92
-
-
EPS (TTM)
-2.5
EPS next Y
0.25
EPS next Q
0.2
EPS this Y
1566.67%
EPS next Y
-110%
EPS next 5Y
-160.2%
EPS last 5Y
NAN%
Revenue last 5Y
7.54%
Revenue Q/Q
-3.09%
EPS Q/Q
-86.94%
-
-
-
-
SMA20
-
SMA50
6.67%
SMA100
77.78%
Inst Own
73.77%
Inst Trans
0.77%
ROA
-8%
ROE
-16%
ROC
0.02%
Gross Margin
57%
Oper. Margin
7%
Profit Margin
-26%
Payout
-
Shs Outstand
492.97M
Shs Float
488.14M
-
-
-
-
Target Price
26.17
52W Range
7.88-16.88
52W High
+1.84%
52W Low
+132.79%
RSI
57
Rel Volume
0.29
Avg Volume
4.48M
Volume
1.28M
Perf Week
0.71%
Perf Month
-0.7%
Perf Quarter
70.45%
Perf Half Y
44.46%
-
-
-
-
Beta
1.297
-
-
Volatility
0.19%, 0.22%
Prev Close
0.77%
Price
16.295
Change
1.91%

ELAN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
8.327.429.789.068.97
Net income per share
0.18-1.27-0.97-0.15-2.5
Operating cash flow per share
0.61-0.090.990.930.55
Free cash flow per share
0.07-0.80.590.550.24
Cash per share
0.911.121.310.740.72
Book value per share
15.0319.215.4714.9512.64
Tangible book value per share
0.2-9.37-8.66-7.27-6.84
Share holders equity per share
15.0319.215.4714.9512.64
Interest debt per share
6.614.2213.4512.4712.29
Market cap
10.87B13.54B13.83B5.96B7.34B
Enterprise value
12.89B19.17B19.51B11.45B12.76B
P/E ratio
160.04-24.17-29.29-80.5-5.96
Price to sales ratio
3.544.142.91.351.66
POCF ratio
48.49-330.1928.6313.1827.07
PFCF ratio
407.01-38.4748.3522.2362.69
P/B Ratio
1.961.61.830.821.18
PTB ratio
1.961.61.830.821.18
EV to sales
4.25.864.092.592.89
Enterprise value over EBITDA
23.7341.5522.8712.9213.5
EV to operating cash flow
57.51-467.5640.3925.3347.07
EV to free cash flow
482.7-54.4868.2142.72109.04
Earnings yield
0.01-0.04-0.03-0.01-0.17
Free cash flow yield
0-0.030.020.040.02
Debt to equity
0.420.720.840.80.93
Debt to assets
0.260.350.380.380.4
Net debt to EBITDA
3.7212.216.666.25.74
Current ratio
2.91.651.991.932.75
Interest coverage
4.340.681.261.491.18
Income quality
3.30.07-1.02-5.79-0.22
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
000.240.240
Research and developement to revenue
0.090.10.080.070.07
Intangibles to total assets
0.610.710.710.70.67
Capex to operating cash flow
-0.887.58-0.41-0.41-0.57
Capex to revenue
-0.06-0.09-0.04-0.04-0.03
Capex to depreciation
-0.63-0.6-0.28-0.27-0.22
Stock based compensation to revenue
0.020.010.010.010.01
Graham number
7.8923.4118.367.1526.67
ROIC
0.040.010.020.030.03
Return on tangible assets
0.02-0.11-0.1-0.02-0.26
Graham Net
-5.18-16.14-14.06-12.97-12.52
Working capital
1.55B1.34B1.63B1.58B2.17B
Tangible asset value
74.5M-4.14B-4.22B-3.55B-3.37B
Net current asset value
-1.07B-5.8B-5.67B-4.92B-4.73B
Invested capital
0.420.720.840.80.93
Average receivables
799.65M983.3M1.05B1.02B1.01B
Average payables
213.9M361.8M459.5M404M330M
Average inventory
1.03B1.31B1.48B1.46B1.64B
Days sales outstanding
105.77120.0678.7582.7883.46
Days payables outstanding
55.26109.7271.4974.4151.04
Days of inventory on hand
260.83345.62234.84293.45327.95
Receivables turnover
3.453.044.644.414.37
Payables turnover
6.613.335.114.917.15
Inventory turnover
1.41.061.551.241.11
ROE
0.01-0.07-0.06-0.01-0.2
Capex per share
-0.53-0.7-0.4-0.38-0.31

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.022.562.182.172.1
Net income per share
-0.110.21-0.2-2.22-0.29
Operating cash flow per share
0.03-0.30.130.40.32
Free cash flow per share
-0.14-0.370.040.330.24
Cash per share
0.730.660.840.750.71
Book value per share
14.9215.2315.312.4512.63
Tangible book value per share
-7.26-6.87-6.8-6.58-6.83
Share holders equity per share
14.9215.2315.312.4512.63
Interest debt per share
12.0712.3912.6512.1411.85
Market cap
5.97B4.62B4.88B5.54B7.34B
Enterprise value
11.46B10.32B10.57B11.08B12.76B
P/E ratio
-27.6411.2-12.58-1.26-13.02
Price to sales ratio
6.043.674.625.197.09
POCF ratio
459.19-31.8479.9927.9746.77
PFCF ratio
-90.45-25.23256.7933.5663.3
P/B Ratio
0.820.620.660.91.18
PTB ratio
0.820.620.660.91.18
EV to sales
11.68.211010.3712.33
Enterprise value over EBITDA
84.2729.8263.764.0386.83
EV to operating cash flow
881.57-71.16173.3555.9581.3
EV to free cash flow
-173.64-56.38556.5367.14110.04
Earnings yield
-0.010.02-0.02-0.2-0.02
Free cash flow yield
-0.01-0.0400.030.02
Debt to equity
0.80.80.820.960.93
Debt to assets
0.380.380.380.410.4
Net debt to EBITDA
40.3816.4834.3132.0236.88
Current ratio
1.932.252.842.822.75
Interest coverage
0.13.310.720.58-0.36
Income quality
-0.24-1.41-0.63-0.18-1.11
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.10000
Research and developement to revenue
0.080.060.080.080.08
Intangibles to total assets
0.70.690.680.650.67
Capex to operating cash flow
-6.080.26-0.69-0.17-0.26
Capex to revenue
-0.08-0.03-0.04-0.03-0.04
Capex to depreciation
-0.47-0.22-0.24-0.19-0.24
Stock based compensation to revenue
0.020.010.010.010.01
Graham number
6.098.488.324.969.02
ROIC
00.01000
Return on tangible assets
-0.010.02-0.02-0.22-0.03
Graham Net
-12.94-12.66-12.79-12.47-12.5
Working capital
1.58B1.97B2.37B2.3B2.17B
Tangible asset value
-3.55B-3.37B-3.3B-3.24B-3.37B
Net current asset value
-4.92B-4.74B-4.72B-4.65B-4.73B
Invested capital
0.80.80.820.960.93
Average receivables
1.02B1.13B1.24B1.18B1.07B
Average payables
370M385.5M367.5M325M283M
Average inventory
1.44B1.57B1.64B1.69B1.71B
Days sales outstanding
91.2890.5104.395.6587.83
Days payables outstanding
78.3569.4173.4154.747.09
Days of inventory on hand
308.97290.77350.46312.32302.62
Receivables turnover
0.990.990.860.941.02
Payables turnover
1.151.31.231.651.91
Inventory turnover
0.290.310.260.290.3
ROE
-0.010.01-0.01-0.18-0.02
Capex per share
-0.16-0.08-0.09-0.07-0.08

ELAN Frequently Asked Questions

What is Elanco Animal Health Incorporated stock symbol ?

Elanco Animal Health Incorporated is a US stock , located in Greenfield of In and trading under the symbol ELAN

Is Elanco Animal Health Incorporated buy or a sell ?

8 stock analysts have 8 predictions with a medium analyst target price of $25. The lowest prediction is $18 and the highest is $37

What is ELAN stock prediction ?

With a median analyst target price of $19, 2 stock analysts have made 2 forecasts in last 90 days. $18 is the lowest and $20 is the greatest projection.

What is Elanco Animal Health Incorporated stock quote today ?

Elanco Animal Health Incorporated stock price is $16.295 today.

Is Elanco Animal Health Incorporated stock public?

Yes, Elanco Animal Health Incorporated is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Same Price Range
Similar Market Cap